tiprankstipranks
Medicinova (MNOV)
NASDAQ:MNOV

Medicinova (MNOV) Technical Analysis

280 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Medicinova’s (MNOV) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Medicinova is a Sell.
Medicinova’s (MNOV) 20-Day exponential moving average is 1.39, while Medicinova’s (MNOV) share price is $1.4, making it a Buy.
Medicinova’s (MNOV) 50-Day exponential moving average is 1.39, while Medicinova’s (MNOV) share price is $1.4, making it a Buy.

Medicinova (MNOV) Pivot Points

Jul 04, 2024, 10:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.35
1.38
1.41
1.44
1.47
1.50
1.53
Fibonacci
1.38
1.40
1.42
1.44
1.46
1.48
1.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Medicinova (MNOV) Moving Averages

Jul 04, 2024, 10:25 AM
Period
Simple
Exponential
MA5
1.43Sell
1.42Sell
MA10
1.39Buy
1.40Sell
MA20
1.38Buy
1.39Buy
MA50
1.38Buy
1.39Buy
MA100
1.39Buy
1.44Sell
MA200
1.57Sell
1.65Sell
Medicinova’s (MNOV) 10-Day exponential moving average is 1.40, while Medicinova’s (MNOV) share price is $1.4, making it a Sell.
Medicinova’s (MNOV) 100-Day exponential moving average is 1.44, while Medicinova’s (MNOV) share price is $1.4, making it a Sell.
Medicinova’s (MNOV) stock price is $1.4 and Medicinova’s (MNOV) 50-day simple moving average is 1.38, creating a Buy signal.
Medicinova’s (MNOV) stock price is $1.4 and Medicinova’s (MNOV) 100-day simple moving average is 1.39, creating a Buy signal.
Medicinova’s (MNOV) stock price is $1.4 and Medicinova’s (MNOV) 200-day simple moving average is 1.57, creating a Sell signal.

Medicinova (MNOV) Technical Indicators

Jul 04, 2024, 10:25 AM
Name
Value
Implied Action
RSI (14)
51.87
Neutral
STOCH (9,6)
80.50
Sell
STOCHRSI (14)
80.50
Sell
MACD (12,26)
0.01
Sell
ADX (14)
15.29
Buy
Williams %R
-36.84
Buy
CCI (14)
66.47
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
51.47
Neutral
ROC
4.48
Buy
Medicinova’s (MNOV) Relative Strength Index (RSI) is 51.87, creating a Neutral signal.
Medicinova’s (MNOV) Trend Strength Indicator (ADX) is 15.29, creating a Buy signal.
Medicinova’s (MNOV) Commodity Channel Index (CCI) is 66.47, creating a Neutral signal.
Medicinova’s (MNOV) Price Rate of Change (ROC) is 4.48, creating a Buy signal.

FAQ

Is MNOV a Buy, Hold, or Sell?
Based on MNOV’s technical indicators, MNOV is a Hold.
    What is MNOV’s RSI (14)?
    MNOV’s RSI (14) is 51.87, which suggests MNOV is a Neutral.
      What is MNOV’s MACD?
      MNOV’s MACD is 0.01, which suggests MNOV is a Sell.
        What is MNOV’s 5-day moving average?
        MNOV’s 5-day moving average is 1.43, which suggests MNOV is a Sell.
          What is MNOV’s 20-day moving average?
          MNOV 20-day moving average is 1.38, which suggests MNOV is a Buy.
            What is MNOV’s 50-day moving average?
            MNOV’s 50-day moving average is 1.38, which suggests MNOV is a Buy.
              What is MNOV’s 200-day moving average?
              MNOV’s 200-day moving average is 1.57, which suggests MNOV is a Sell.
                What is MNOV’s Williams % R (14)?
                MNOV’s Williams % R (14) is -36.84, which suggests MNOV is a Buy.
                  What is MNOV’s CCI (14)?
                  MNOV’s CCI (14) is 66.47, which suggests MNOV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis